Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$111M |
| 2 |
Ferguson
FERG
|
+$106M |
| 3 |
Apple
AAPL
|
+$103M |
| 4 |
Amazon
AMZN
|
+$103M |
| 5 |
Tesla
TSLA
|
+$75.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TIF
Tiffany & Co.
TIF
|
+$96.7M |
| 2 |
DuPont de Nemours
DD
|
+$51.9M |
| 3 |
CXO
CONCHO RESOURCES INC.
CXO
|
+$43.4M |
| 4 |
AvalonBay Communities
AVB
|
+$36.1M |
| 5 |
Equity Residential
EQR
|
+$21.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.7% |
| 2 | Healthcare | 14.14% |
| 3 | Consumer Discretionary | 13.71% |
| 4 | Communication Services | 10.92% |
| 5 | Industrials | 9.14% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2301
National Presto Industries
NPK
$988M
| $1.13M | ﹤0.01% |
11,100
| – | – |
|
2302
Phibro Animal Health
PAHC
$1.38B
| $1.13M | ﹤0.01% |
46,400
+1,200
| +3% | +$27.1K |
|
2303
ARKO Corp
ARKO
$500M
| $1.13M | ﹤0.01% |
113,461
+48,400
| +74% | +$451K |
|
2304
Independent Bank Corp
IBCP
$851M
| $1.13M | ﹤0.01% |
47,700
| – | – |
|
|
PRVB
2305
DELISTED
Provention Bio, Inc. Common Stock
PRVB
| $1.13M | ﹤0.01% |
107,500
+18,400
| +21% | +$259K |
|
2306
MBIA
MBI
$258M
| $1.13M | ﹤0.01% |
117,100
-6,900
| -6% | -$53.4K |
|
2307
HCI Group
HCI
$2.3B
| $1.12M | ﹤0.01% |
14,600
| – | – |
|
2308
TherapeuticsMD
TXMD
$24.2M
| $1.12M | ﹤0.01% |
16,744
+5,600
| +50% | +$438K |
|
|
GOCO
2309
DELISTED
GoHealth
GOCO
| $1.11M | ﹤0.01% |
6,347
| – | – |
|
2310
Geron
GERN
$994M
| $1.11M | ﹤0.01% |
703,400
| – | – |
|
2311
Forrester Research
FORR
$223M
| $1.11M | ﹤0.01% |
26,050
+500
| +2% | +$21.7K |
|
|
AD
2312
Array Digital Infrastructure
AD
$3.08B
| $1.1M | ﹤0.01% |
30,300
| – | – |
|
2313
A10 Networks
ATEN
$1.98B
| $1.1M | ﹤0.01% |
114,500
| – | – |
|
|
DCBO
2314
Docebo
DCBO
$565M
| $1.1M | ﹤0.01% |
25,600
| – | – |
|
2315
Bank of Marin Bancorp
BMRC
$464M
| $1.1M | ﹤0.01% |
28,000
+700
| +3% | +$27K |
|
2316
Nano X Imaging
NNOX
$74.3M
| $1.09M | ﹤0.01% |
26,300
| – | – |
|
|
DHIL
2317
DELISTED
Diamond Hill
DHIL
| $1.08M | ﹤0.01% |
6,954
| – | – |
|
|
MOFG
2318
DELISTED
MidWestOne Financial Group
MOFG
| $1.08M | ﹤0.01% |
35,000
+700
| +2% | +$19.9K |
|
2319
First Community Bankshares
FCBC
$932M
| $1.08M | ﹤0.01% |
36,079
| – | – |
|
|
BFX
2320
DELISTED
BowFlex Inc.
BFX
| $1.08M | ﹤0.01% |
69,200
+1,400
| +2% | +$30.1K |
|
2321
Waterstone Financial
WSBF
$381M
| $1.08M | ﹤0.01% |
52,900
| – | – |
|
2322
Omega Flex
OFLX
$285M
| $1.07M | ﹤0.01% |
6,800
| – | – |
|
|
SPPI
2323
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $1.07M | ﹤0.01% |
329,500
| – | – |
|
2324
Willdan Group
WLDN
$1.29B
| $1.06M | ﹤0.01% |
25,900
| – | – |
|
2325
Akebia Therapeutics
AKBA
$245M
| $1.06M | ﹤0.01% |
313,785
+9,700
| +3% | +$34.9K |
|
Similar funds
Swiss National Bank's Q1 2021 Portfolio in Review
As of Q1 2021, Swiss National Bank held 2,502 positions worth $150B, up 6.6% from $141B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Trading was light in Q1 2021: portfolio turnover was 1.3%. Swiss National Bank opened 12 new positions and exited 20, leaving the 2,502-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 26% of assets, down from 26% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Swiss National Bank's largest Q1 2021 buy was Ferguson: 872,392 shares worth $104M.
- Swiss National Bank added most to Microsoft in Q1 2021, an estimated $111M increase.
- Swiss National Bank's biggest Q1 2021 reduction was DuPont de Nemours, cutting an estimated $51.9M.
- Swiss National Bank fully exited Tiffany & Co. in Q1 2021, selling an estimated $96.7M.
- Swiss National Bank's ten largest holdings make up 23% of its $150B portfolio in Q1 2021.
- Swiss National Bank opened 12 new positions and closed 20 in Q1 2021.
- Swiss National Bank's portfolio value rose 6.6% quarter-over-quarter to $150B.
Based on Swiss National Bank's 13F filing for Q1 2021, filed 7 May 2021.